Association of minimum inhibitory concentration with outcome in patients with Stenotrophomonas maltophilia bacteraemia treated with empirical levofloxacin
Abstract
Stenotrophomonas maltophilia is intrinsically resistant to carbapenems and most β-lactam antibiotics. Empiric therapy for bloodstream infections often includes either trimethoprim-sulfamethoxazole or levofloxacin. However, there are currently no European Committee on Antimicrobial Susceptibility Testing (EUCAST) breakpoints available for interpretation of susceptibility testing for levofloxacin. We examined the relationship between levofloxacin minimum inhibitory concentration (MIC) and clinical outcomes in S. maltophilia bacteraemia. We retrospectively examined 79 consecutive patients with S. maltophilia bacteraemia from a single centre who received empiric antibiotic therapy with levofloxacin from 1 January 2012 to 30 June 2024. Adverse outcomes were defined as all-cause in-hospital mortality and were compared against the levofloxacin MIC, as tested by ETEST. Of the 79 patients, 28 (35.4%) experienced in-hospital mortality. A majority of infections were central-line related, which had comparatively better outcomes than pneumonia or intra-abdominal infections. A majority of infections were acquired nosocomially, and patients often had exposure to carbapenems prior to presentation. The MIC ranged from 0.125 mg/L to ≥32 mg/L, with MIC50 and MIC90 of 1 mg/L and 2 mg/L, respectively. Increasing frequency of adverse outcomes was observed at higher MIC cut-offs. Mortality was 100% at an MIC ≥4 mg/L. Adverse outcomes were common in S. maltophilia bacteraemia. In patients treated…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 79 participants or records.
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Neuroprotective Effects of Epicatechin against Oxidative Stress-Induced Cognitive Impairment: A Systematic Review and Meta-Analysis
- Photochemical behavior of levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.